{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T12:13:03Z","timestamp":1762603983280},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2016,1,29]],"date-time":"2016-01-29T00:00:00Z","timestamp":1454025600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Deliv. and Transl. Res."],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1007\/s13346-016-0280-4","type":"journal-article","created":{"date-parts":[[2016,1,29]],"date-time":"2016-01-29T16:55:37Z","timestamp":1454086537000},"page":"210-224","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Design and optimization of gastro-retentive microballoons for enhanced bioavailability of cinnarizine"],"prefix":"10.1007","volume":"6","author":[{"given":"Hussein O.","family":"Ammar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahmoud","family":"Ghorab","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rabab","family":"Kamel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alaa H.","family":"Salama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,1,29]]},"reference":[{"key":"280_CR1","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1111\/j.2042-7158.1978.tb13366.x","volume":"30","author":"H Bechgaard","year":"1978","unstructured":"Bechgaard H, Ladefoged K. Distribution of pellets in the gastrointestinal tract. The influence on transit time exerted by the density or diameter of pellets. J Pharm Pharmacol. 1978;30:690\u20132.","journal-title":"J Pharm Pharmacol"},{"key":"280_CR2","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3109\/03639047809055639","volume":"4","author":"H Bechgaard","year":"1978","unstructured":"Bechgaard H, Nielson GH. Controlled release multiple units and single unit doses. Drug Dev Ind Pharm. 1978;4:53\u201367.","journal-title":"Drug Dev Ind Pharm"},{"key":"280_CR3","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0378-5173(94)00311-R","volume":"116","author":"C Vervaet","year":"1995","unstructured":"Vervaet C, Baert L, Remon JP. Extrusion-spheronization: a literature review. Int J Pharm. 1995;116:131\u201346.","journal-title":"Int J Pharm"},{"issue":"3","key":"280_CR4","doi-asserted-by":"crossref","first-page":"329","DOI":"10.3109\/02652040309178073","volume":"20","author":"A Streubel","year":"2003","unstructured":"Streubel A, Siepmann J, Bodmeier R. Multiple unit gastroretentive drug delivery systems: a new preparation method for low density microparticles. J Microencapsul. 2003;20(3):329\u201347.","journal-title":"J Microencapsul"},{"issue":"6","key":"280_CR5","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/S0149-2918(04)90130-0","volume":"26","author":"AW Scholtz","year":"2004","unstructured":"Scholtz AW et al. Treatment of vertigo due to acute unilateral vestibular loss with a fixed combination of cinnarizine and dimenhydrinate: a double-blind, randomized, parallel-group clinical study. Clin Ther. 2004;26(6):866\u201377.","journal-title":"Clin Ther"},{"key":"280_CR6","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ijpharm.2011.05.079","volume":"416","author":"MA Alhnan","year":"2011","unstructured":"Alhnan MA, Murdan S, Basit AW. Encapsulation of poorly soluble basic drugs into enteric microparticles: a novel approach to enhance their oral bioavailability. Int J Pharm. 2011;416:55\u201360.","journal-title":"Int J Pharm"},{"issue":"2","key":"280_CR7","first-page":"115","volume":"8","author":"M Novotny","year":"2002","unstructured":"Novotny M, Kostrica R. Fixed combination of cinnarizine and dimenhydrinate vs betahistine dimesylate in the treatment of Meniere\u2019s disease: a randomized, double-blind, parallel group clinical study. Int Tinnitus J. 2002;8(2):115\u201323.","journal-title":"Int Tinnitus J"},{"issue":"3","key":"280_CR8","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1111\/j.1526-4610.2006.00381.x","volume":"46","author":"M Togha","year":"2006","unstructured":"Togha M, Ashrafian H, Tajik P. Open-label trial of cinnarizine in migraine prophylaxis. Headache. 2006;46(3):498\u2013502.","journal-title":"Headache"},{"issue":"5","key":"280_CR9","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1542\/peds.2005-2059","volume":"117","author":"D Turner","year":"2006","unstructured":"Turner D et al. Pediatric cinnarizine overdose and toxicokinetics. Pediatrics. 2006;117(5):1067\u20139.","journal-title":"Pediatrics"},{"key":"280_CR10","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.ijpharm.2009.09.025","volume":"383","author":"S Shi","year":"2010","unstructured":"Shi S et al. Pharmacokinetics, tissue distribution and safety of cinnarizine delivered in lipid emulsion. Int J Pharm. 2010;383:264\u201370.","journal-title":"Int J Pharm"},{"key":"280_CR11","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ijpharm.2005.05.042","volume":"302","author":"T Loftsson","year":"2005","unstructured":"Loftsson T, Hreinsd\u00f3ttir D, M\u00e1sson M. Evaluation of cyclodextrin solubilization of drugs. Int J Pharm. 2005;302:18\u201328.","journal-title":"Int J Pharm"},{"key":"280_CR12","first-page":"51","volume":"2","author":"BS Kalava","year":"2005","unstructured":"Kalava BS, Demirel M, Yazan Y. Physicochemical characterisation and dissolution properties of cinnarizine solid dispersions. Turk J Pharm Sci. 2005;2:51\u201362.","journal-title":"Turk J Pharm Sci"},{"issue":"4","key":"280_CR13","first-page":"426","volume":"1","author":"RS Radke","year":"2008","unstructured":"Radke RS et al. Formulation and evaluation of sustained release system for an effective management of motion sickness. RJPT. 2008;1(4):426\u20139.","journal-title":"RJPT"},{"issue":"1","key":"280_CR14","doi-asserted-by":"crossref","first-page":"139","DOI":"10.2165\/00003495-200060010-00008","volume":"60","author":"LJ Scott","year":"2000","unstructured":"Scott LJ, Perry CM. Tramadol: a review of its use in perioperative pain. Drugs. 2000;60(1):139\u201376.","journal-title":"Drugs"},{"key":"280_CR15","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.ijpharm.2009.04.045","volume":"376","author":"L Chang","year":"2009","unstructured":"Chang L et al. Optimization of epirubicin nanoparticles using experimental design for enhanced intravesical drug delivery. Int J Pharm. 2009;376:195\u2013203.","journal-title":"Int J Pharm"},{"key":"280_CR16","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3109\/03639049609041979","volume":"22","author":"R Renoux","year":"1996","unstructured":"Renoux R et al. Experimentally designed optimization of direct compression tablets. Drug Dev Ind Pharm. 1996;22:103\u20139.","journal-title":"Drug Dev Ind Pharm"},{"key":"280_CR17","first-page":"84","volume-title":"Design and analysis of experiments","author":"D Montgomery","year":"1997","unstructured":"Montgomery D. Design and analysis of experiments. New York: Wiley; 1997. p. 84\u20136."},{"key":"280_CR18","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1081\/DMR-100104401","volume":"33","author":"KS Soppimath","year":"2001","unstructured":"Soppimath KS et al. Microspheres as floating drug delivery system to increase the gastric residence of drugs. Drug Metab Rev. 2001;33:149\u201360.","journal-title":"Drug Metab Rev"},{"key":"280_CR19","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1080\/02652040310001619983","volume":"21","author":"WM Obeidat","year":"2004","unstructured":"Obeidat WM, Price JC. Evaluation of enteric matrix microspheres prepared by emulsion-solvent evaporation using scanning electron microscopy. J Microencapsul. 2004;21:47\u201357.","journal-title":"J Microencapsul"},{"issue":"3","key":"280_CR20","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1080\/02652040500100907","volume":"22","author":"WM Obeidat","year":"2005","unstructured":"Obeidat WM, Price JC. Preparation and in vitro evaluation of propylthiouracil microspheres made of Eudragit RL 100 and cellulose acetate butyrate polymers using the emulsion-solvent evaporation method. J Microencapsul. 2005;22(3):281\u20139.","journal-title":"J Microencapsul"},{"key":"280_CR21","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1081\/DDC-120021779","volume":"29","author":"Y Miyazaki","year":"2003","unstructured":"Miyazaki Y et al. Release profiles of theophylline from microspheres consisting of dextran derivatives and cellulose acetate butyrate: effect of polyion complex formation. Drug Dev Ind Pharm. 2003;29:795\u2013804.","journal-title":"Drug Dev Ind Pharm"},{"key":"280_CR22","doi-asserted-by":"crossref","first-page":"2764","DOI":"10.1002\/app.26456","volume":"105","author":"AP Rokhade","year":"2007","unstructured":"Rokhade AP et al. Preparation and evaluation of cellulose acetate butyrate and poly(ethylene oxide) blend microspheres for gastroretentive floating delivery of repaglinide. J Appl Polym Sci. 2007;105:2764\u201371.","journal-title":"J Appl Polym Sci"},{"key":"280_CR23","first-page":"255","volume-title":"Treatise on controlled drug delivery","author":"PK Gupta","year":"1992","unstructured":"Gupta PK, Robinson JR. Oral controlled-release delivery. In: Kydonieus A, editor. Treatise on controlled drug delivery. New York: Marcel Dekker; 1992. p. 255\u2013313."},{"key":"280_CR24","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ijpharm.2006.11.060","volume":"336","author":"Y Tang","year":"2007","unstructured":"Tang Y et al. Sustained release of hydrophobic and hydrophilic drugs from a floating dosage form. Int J Pharm. 2007;336:159\u201365.","journal-title":"Int J Pharm"},{"key":"280_CR25","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/jps.2600810207","volume":"81","author":"Y Kawashima","year":"1992","unstructured":"Kawashima Y et al. Hollow microspheres for use as a floating controlled drug delivery system in the stomach. J Pharm Sci. 1992;81:135\u201340.","journal-title":"J Pharm Sci"},{"key":"280_CR26","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.ejpb.2004.03.037","volume":"58","author":"YB Huang","year":"2004","unstructured":"Huang YB et al. Once-daily propranolol extended-release tablet dosage form: formulation design and in vitro\/in vivo investigation. Eur J Pharm Biopharm. 2004;58:607\u201314.","journal-title":"Eur J Pharm Biopharm"},{"issue":"1","key":"280_CR27","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jsps.2011.08.004","volume":"21","author":"MM Ahmed","year":"2013","unstructured":"Ahmed MM et al. Emulsification\/internal gelation as a method for preparation of diclofenac sodium-sodium alginate microparticles. Saudi Pharm J. 2013;21(1):61\u20139.","journal-title":"Saudi Pharm J"},{"key":"280_CR28","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0939-6411(03)00003-1","volume":"55","author":"Y Sato","year":"2003","unstructured":"Sato Y et al. Physicochemical properties to determine the buoyancy of hollow microspheres (microballoons) prepared by the emulsion solvent diffusion method. Eur J Pharm Biopharm. 2003;55:297\u2013304.","journal-title":"Eur J Pharm Biopharm"},{"key":"280_CR29","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0939-6411(03)00185-1","volume":"57","author":"Y Sato","year":"2004","unstructured":"Sato Y et al. In vitro evaluation of floating and drug releasing behaviors of hollow microspheres (microballoons) prepared by the emulsion solvent diffusion method. Eur J Pharm Biopharm. 2004;57:235\u201343.","journal-title":"Eur J Pharm Biopharm"},{"issue":"6","key":"280_CR30","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1177\/00970002042006005","volume":"42","author":"MN Martinez","year":"2002","unstructured":"Martinez MN, Amidon GL. A mechanistic approach to understanding the factors affecting drug absorption: a review of fundamentals. J Clin Pharmacol. 2002;42(6):620\u201343.","journal-title":"J Clin Pharmacol"},{"issue":"2","key":"280_CR31","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.jconrel.2005.06.007","volume":"107","author":"SK Jain","year":"2005","unstructured":"Jain SK et al. Calcium silicate based microspheres of repaglinide for gastroretentive floating drug delivery: preparation and in vitro characterization. J Control Release. 2005;107(2):300\u20139.","journal-title":"J Control Release"},{"issue":"2","key":"280_CR32","first-page":"30","volume":"8","author":"DM Patel","year":"2007","unstructured":"Patel DM et al. Floating granules of ranitidine hydrochloride-gelucire 43\/01: formulation optimization using factorial design. AAPS Pharm Sci Tech. 2007;8(2):30.","journal-title":"AAPS Pharm Sci Tech"},{"issue":"1\u20132","key":"280_CR33","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.ijpharm.2004.01.036","volume":"275","author":"Y Sato","year":"2004","unstructured":"Sato Y et al. In vitro and in vivo evaluation of riboflavin-containing microballoons for a floating controlled drug delivery system in healthy humans. Int J Pharm. 2004;275(1\u20132):97\u2013107.","journal-title":"Int J Pharm"},{"issue":"3","key":"280_CR34","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1080\/02652040601162723","volume":"24","author":"J Varshosaz","year":"2007","unstructured":"Varshosaz J, Tabbakhian M, Zahrooni M. Development and characterization of floating microballoons for oral delivery of cinnarizine by a factorial design. J Microencapsul. 2007;24(3):253\u201362.","journal-title":"J Microencapsul"},{"issue":"5","key":"280_CR35","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1080\/02652040801973101","volume":"25","author":"VS Mastiholimath","year":"2008","unstructured":"Mastiholimath VS et al. In vitro and in vivo evaluation of ranitidine hydrochloride ethyl cellulose floating microparticles. J Microencapsul. 2008;25(5):307\u201314.","journal-title":"J Microencapsul"},{"key":"280_CR36","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ijpharm.2007.03.049","volume":"341","author":"PR Nepal","year":"2007","unstructured":"Nepal PR, Chun M, Choi H. Preparation of floating microspheres for fish farming. Int J Pharm. 2007;341:85\u201390.","journal-title":"Int J Pharm"},{"key":"280_CR37","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/0168-3659(91)90004-W","volume":"16","author":"Y Kawashima","year":"1991","unstructured":"Kawashima Y et al. Preparation of multiple unit hollow microspheres (microballoons) with acrylic resin containing tranilast and their drug release characteristics (in vitro) and floating behavior (in vivo). J Control Release. 1991;16:279\u201390.","journal-title":"J Control Release"},{"issue":"3","key":"280_CR38","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3109\/1061186X.2012.747527","volume":"21","author":"R Kamel","year":"2013","unstructured":"Kamel R, Basha M, Elawdan S. Development and evaluation of long-acting epidural \u201csmart\u201d thermoreversible injection loaded with spray-dried polymeric nanospheres using experimental design. J Drug Target. 2013;21(3):277\u201390.","journal-title":"J Drug Target"},{"issue":"8","key":"280_CR39","first-page":"43","volume":"2","author":"A Birajdar","year":"2012","unstructured":"Birajdar A et al. Design and evaluation of glipizide containing microballoons for floating controlled drug delivery system. IJPI\u2019s J Pharm Cosmet. 2012;2(8):43\u20135.","journal-title":"IJPI\u2019s J Pharm Cosmet"},{"issue":"5","key":"280_CR40","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.ijbiomac.2012.07.030","volume":"51","author":"A Hooda","year":"2012","unstructured":"Hooda A et al. Optimization and evaluation of gastroretentive ranitidine HCl microspheres by using design expert software. Int J Biol Macromol. 2012;51(5):691\u2013700.","journal-title":"Int J Biol Macromol"},{"issue":"3","key":"280_CR41","first-page":"193","volume":"19","author":"A Porwal","year":"2011","unstructured":"Porwal A, Swami G, Saraf S. Preparation and evaluation of sustained release microballoons of propranolol. DARU. 2011;19(3):193\u2013201.","journal-title":"DARU"},{"issue":"2","key":"280_CR42","first-page":"157","volume":"9","author":"A Sood","year":"1999","unstructured":"Sood A, Panchagnula R. Role of dissolution studies in controlled release drug delivery system. STP Pharma Sci. 1999;9(2):157\u201368.","journal-title":"STP Pharma Sci"},{"issue":"4","key":"280_CR43","doi-asserted-by":"crossref","first-page":"468","DOI":"10.3109\/03639045.2011.611807","volume":"38","author":"R Kamel","year":"2012","unstructured":"Kamel R, Mahmoud A, El-Feky G. Double-phase hydrogel for buccal delivery of tramadol. Drug Dev Ind Pharm. 2012;38(4):468\u201383.","journal-title":"Drug Dev Ind Pharm"},{"key":"280_CR44","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.2042-7158.1993.tb03672.x","volume":"45","author":"BC Thanoo","year":"1993","unstructured":"Thanoo BC, Sunny MC, Jayakrishnan A. Oral sustained release drug delivery systems using polycarbonate microspheres capable of floating on the gastric fluids. J Pharm Pharmacol. 1993;45:21\u20134.","journal-title":"J Pharm Pharmacol"},{"issue":"1","key":"280_CR45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF02980037","volume":"27","author":"Y Yeo","year":"2004","unstructured":"Yeo Y, Park K. Control of encapsulation efficiency and initial burst in polymeric microparticle systems. Arch Pharm Res. 2004;27(1):1\u201312.","journal-title":"Arch Pharm Res"},{"key":"280_CR46","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.ijpharm.2010.03.008","volume":"391","author":"EB Basalious","year":"2010","unstructured":"Basalious EB, Shawky N, Badr-Eldin SM. SNEDDS containing bioenhancers for improvement of dissolution and oral absorption of lacidipine. I: development and optimization. Int J Pharm. 2010;391:203\u201311.","journal-title":"Int J Pharm"}],"container-title":["Drug Delivery and Translational Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-016-0280-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13346-016-0280-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-016-0280-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T15:55:16Z","timestamp":1559490916000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13346-016-0280-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,29]]},"references-count":46,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["280"],"URL":"https:\/\/doi.org\/10.1007\/s13346-016-0280-4","relation":{},"ISSN":["2190-393X","2190-3948"],"issn-type":[{"value":"2190-393X","type":"print"},{"value":"2190-3948","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,29]]}}}